Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Κύριοι συγγραφείς: Rory Barry (Συγγραφέας), Gregg Murray (Συγγραφέας), Sally McGrath (Συγγραφέας), Clive Kilgallen (Συγγραφέας), Karen Eustace (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2024-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...